BIOVECTRA
BIOVECTRA is a North American contract development and manufacturing organization (CDMO) specializing in clinical-to-commercial scale production capabilities for biologics, synthetic small molecules, pDNA and mRNA, highly potent active pharmaceutical ingredients (APIs) and bioreagents. They thrive on the vexing challenges few CDMOs would have the expertise or desire to address. Bold vision, along with the passion and commitment to make that vision a reality, is at the heart of their organization.
Latest BIOVECTRA Content
Listicle
Cell Therapy: Clinical Applications, Manufacturing and Regulation
Download this listicle to learn more about the applications of cell therapy, the regulatory landscape of cell therapy, and manufacturing and scalability challenges.
Product News
Biovectra Signs Service Agreement With Acuitas Therapeutics for Unique Lipid Nanoparticle (Lnp) Delivery System Used in Manufacturing mRNA-Based Therapies
Partnership between two Canadian life sciences leaders offers a commercial GMP manufacturing solution for Acuitas’ licensed partners developing promising next generation therapies.
Whitepaper
Discover Single-Use Fermenters for Biopharmaceutical Production
Single-use fermenters (SUFs) use disposable sterile plastic bags that don’t require the traditional high-intensity preparation of SS bioreactors, which are expensive and time-consuming processes.
Advertisement
